Control of GPCRs in space and time

For cells to be healthy, proteins and lipid must be moved between organelles with high spatial and temporal fidelity. Collectively, movement along these cellular highways is called membrane trafficking. Underscoring its importance, multiple human diseases—including Alzheimer’s, Parkinson’s, and Charcot-Marie-Tooth—have links to mutations in cellular proteins responsible for membrane trafficking. Our goal is to map the proteins which control trafficking of GPCRs—from protein synthesis (cradle) to degradation (grave). By mapping the highways and byways of the cell, we will gain insights into how membrane trafficking operates under normal conditions and is perturbed during disease.

We are presently focusing on:

•How does the endosome determine the distinct fates of activated GPCRs? What are the molecular mechanisms which recognize one type of GPCR and save it from lysosomal degradation while selecting another type of GPCR for destruction?

•How does endosomal sorting of opioid receptors affect the development of opioid tolerance?

 

Retromer Opposes Opioid-Induced Downregulation of the Mu Opioid Receptor Dagunts A, Adoff H, Novy B, De Maria M, Lobingier BT. BioRxiv, 2024.

 

An engineered trafficking biosensor reveals a role for DNAJC13 in DOR downregulation regulation Novy B, Dagunts A, Weishaar T, Holland E, Adoff H, Hutchinson E, De Maria M, Kampann M, Tsvetanova NG, Lobingier BT. Nature Chemical Biology, 2024.